Tevard's tRNA Therapy Restores 70% Protein in Muscular Dystrophy
September 29, 2025 — Tevard Biosciences reveals breakthrough tRNA therapy restoring 70% protein in Duchenne muscular dystrophy & dilated cardiomyopathy models. New preclinical data shows sustained benefits.